Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4/A Registration of securities issued in business combination transactions
- 23.1 Consent of Wolf & Co., Independent Registered Public Accounting Firm
- 23.3 Consent of Citrin Cooperman & Company LLP, Independent Registered Public Accounting Firm
- 99.2 Consent of Rna Advisors, LLC
- Download Excel data file
- View Excel data file
Associated filings
- 6 Feb 24 424B3 Prospectus supplement
- 22 Jan 24 424B3 Prospectus supplement
- 22 Jan 24 EFFECT Notice of effectiveness
- 16 Jan 24 S-4/A Registration of securities issued in business combination transactions (amended)
- 8 Jan 24 S-4/A Registration of securities issued in business combination transactions (amended)
- 15 Dec 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 11 Aug 23 S-4/A Registration of securities issued in business combination transactions (amended)
-
19 Jul 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 6 Jun 23 S-4 Registration of securities issued in business combination transactions
CERO similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to use in this Amendment No. 1 to the Registration Statement (No. 333-272467) on Form S-4 of Phoenix Biotech Acquisition Corp. of our report dated May 8, 2023, relating to the financial statements of CERo Therapeutics Inc., appearing in the Prospectus, which is part of this Registration Statement.
We also consent to the reference to our firm under the caption “Experts” in such Prospectus.
/s/ Wolf & Company, P.C.
Wolf & Company, P.C.
Boston, Massachusetts
July 19, 2023